Journal of Clinical Oncology, Vol 18, No 21S (November 1 Supplement)
2000: 65s-69s
© 2000 American Society for Clinical Oncology
STATE-OF-THE-ART: CLINICAL CANCER GENETICS IN THE NEW MILLENNIUM |
Organizing Cancer Genetics Programs: The Swiss Model
By Gabriella Pichert,
Rolf Arno Stahel,
for the Swiss Institute for Applied Cancer Research Network for Cancer Predisposition Testing and Counseling
From the Division of Oncology, Department of Medicine, University Hospital, Zürich, Switzerland.
Address reprint requests to Gabriella Pichert, MD, Division of Oncology, Department of Medicine, University Hospital, Rämistrasse 100, 8091 Zürich, Switzerland; email onkpib{at}usz.unizh.ch
PURPOSE: Inherited predisposition to cancer is a complex issue, and risk assessment, counseling, and management are multidisciplinary tasks. An infrastructure is needed through which clinical services may be delivered and research activities conducted.
METHODS: The Swiss Institute for Applied Cancer Research (SIAK) Network for Cancer Predisposition Testing and Counseling was established in 1999. The goals of the Network are to set common standards for clinical services, to coordinate research activities, to address psychosocial and ethical issues concerning genetic counseling and testing, and to translate the knowledge gained into medical practice.
RESULTS: An algorithm for genetic testing and counseling of the families studied by the SIAK Network centers has been established in a consensual process. Eight regional centers currently operate according to this algorithm. Furthermore, a proposal has been submitted for the setup of a Swiss databank for the characterization of BRCA1 and BRCA2 mutation patterns and the identification of potentially unique mutations in probands who seek genetic counseling and testing at the respective centers of the SIAK Network.
CONCLUSION: Our coordinated effort will ensure state-of-the-art genetic testing and counseling services in Switzerland and will allow us to acquire knowledge for appropriate risk assessment and surveillance/prevention strategies for individuals with an inherited cancer predisposition.
|
